Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Such trials, using standardized biomarker panels, clinical endpoints that are uniform, and sufficiently long-term follow-up, can give definitive results
Antioxidants (Basel) 10, 1837
Group 3: Received the same levofloxacin treatment
Despite significant advancements in cancer care, especially the development of targeted anticancer therapies, the mechanisms of protecting cells from cytotoxic compounds mediated by tumorhost interactions continue to play a primary role as obstacles to cancer therapy
US$ 28.92
US$ 28.56
US$ 25.68
US$ 21.53
US$ 27.63
